Publicaciones en las que colabora con ANDRÉS SÁNCHEZ PERNAUTE (19)

2019

  1. Beneficial effect of bariatric surgery on abnormal MMP-9 and AMPK activities: Potential markers of obesity-related CV risk

    Frontiers in Physiology, Vol. 10, Núm. MAY

2016

  1. Clinical relevance of telomere status and telomerase activity in colorectal cancer

    PLoS ONE, Vol. 11, Núm. 2

2015

  1. Prognostic value of telomere function in gastric cancers with and without microsatellite instability

    European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 2, pp. 162-169

2011

  1. Expression of human MDGA1 increases cell motility and cell-cell adhesion and reduces adhesion to extracellular matrix proteins in MDCK cells

    Cancer Microenvironment, Vol. 4, Núm. 1, pp. 23-32

2010

  1. MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway

    International Journal of Oncology, Vol. 36, Núm. 5, pp. 1209-1215

2008

  1. Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability

    Clinical Cancer Research, Vol. 14, Núm. 4, pp. 995-1001

2007

  1. Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma

    Hepato-Gastroenterology, Vol. 54, Núm. 73, pp. 315-319

2006

  1. Correlations of telomere length, telomerase activity, and telomerlc-repeat binding factor 1 expression in colorectal carcinoma: Prognostic indications

    Cancer, Vol. 106, Núm. 3, pp. 541-551

2005

  1. Characterization of MDGA1, a novel human glycosylphosphatidylinositol- anchored protein localized in lipid rafts

    Experimental Cell Research, Vol. 307, Núm. 1, pp. 91-99

  2. Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer

    Oncology Reports, Vol. 13, Núm. 1, pp. 115-120

2004

  1. Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: clinical implications.

    International journal of oncology, Vol. 24, Núm. 2, pp. 349-355

  2. Relationship between 3p deletions and telomerase activity in non-small-cell lung cancer: Prognostic implications

    British Journal of Cancer, Vol. 90, Núm. 10, pp. 1983-1988

2002

  1. Cooperative role of telomerase activity and p16 expression in the prognosis of non-small-cell lung cancer

    Journal of Clinical Oncology, Vol. 20, Núm. 1, pp. 254-262

  2. Genomic organization of a novel glycosylphosphatidylinositol MAM gene expressed in human tissues and tumors

    Oncogene, Vol. 21, Núm. 19, pp. 3089-3094

  3. Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors

    Cancer Research, Vol. 62, Núm. 13, pp. 3855-3860

2000

  1. Detection of telomerase activity in human carcinomas using a trap-ELISA method: correlation with hTR and hTERT expression.

    International journal of oncology, Vol. 16, Núm. 3, pp. 623-628

  2. Loss of heterozygosity at 3p23 is correlated with poor survival in patients with colorectal carcinoma

    Cancer, Vol. 89, Núm. 6, pp. 1220-1227

1999

  1. Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer

    European Journal of Cancer, Vol. 35, Núm. 12, pp. 1676-1682

1998

  1. Prognostic significance of p53 gene mutations in squamous cell carcinoma of the lung

    Oncology Reports, Vol. 5, Núm. 5, pp. 1129-1133